TELA Bio’s OviTex Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021

TELA Bio

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced three upcoming poster presentations on its OviTex Reinforced Tissue Matrix portfolio. Data demonstrating the effectiveness of OviTex in a variety of hernia repairs will be presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) conference from August 31 through September 3, 2021, in Las Vegas, Nevada.

“We are thankful to the surgeons who have followed their patients’ outcomes and are presenting at SAGES. Hernia repair is a challenging problem, but data such as the research on our OviTex portfolio to be presented at SAGES demonstrates that when you meaningfully collaborate with surgeons, you can solve problems and improve outcomes,” said Antony Koblish, CEO of TELA Bio. “Our unique platform allowed us to build a portfolio of products which can be utilized through multiple surgical techniques to help repair a variety of hernia types. In addition, our flexible platform and dedication to incorporating surgeon feedback are essential in developing innovative solutions for soft tissue reconstruction.”

Designed by leading experts, with collaboration from more than 100 surgeons, OviTex Reinforced Tissue Matrix is an advanced hernia repair technology that utilizes naturally sourced tissue reinforced with interwoven polymer fibers to facilitate tissue remodeling while optimizing strength and minimizing the foreign body inflammatory response. This comprehensive portfolio is designed to address multiple hernia types and enables surgeons to select the implant best suited for the patient’s specific needs.

“Dr. Banaschak and I are excited that SAGES has recognized our work and look forward to sharing our positive results with OviTex,” said Paul Szotek, MD, Medical Director of the Indiana Hernia Center. “I began utilizing OviTex in my practice in 2016 with the interest of reducing the amount of permanent synthetic polymer exposure for my patients. Over the last five years, we’ve optimized our results by leveraging OviTex’s unique design along with proven surgical techniques to develop what we refer to as the Reinforced Biologic Augmented Repair or ReBAR.”

READ:  Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000

“I’m pleased to be sharing the results of my use of OviTex in a series of patients requiring bridged hernia repairs at SAGES,” said George DeNoto III, MD, FACS, director of General Surgery St. Francis Hospital in New York. “These patients represent some of the most challenging patients that we encounter as general surgeons, and these data are very promising.”

Poster presentations include:
1. A Reinforced Biologic Augmented Repair (ReBAR) of Coexisting Inguinal and Incisional Hernias, 619 Patients, with Robotic Assistance (Cory Banaschak, M.D. and Paul Szotek, MD, MBA, FACS);

  1. Robotic-Assisted ReBAR of 111 Inguinal Hernias (Cory Banaschak, MD and Paul Szotek, M.D., MBA, FACS); and

  2. Use of Ovine Reinforced Tissue Matrix in Bridged Incisional Hernia Repair (George DeNoto III, MD, FACS).

For the event’s full agenda, visit https://www.sages2021.surgery/schedule-at-a-glance/.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.

Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.